Jun-ichi Takanashi1, Hitoshi Osaka2, Hirotomo Saitsu3, Masayuki Sasaki4, Harushi Mori5, Hidehiro Shibayama6, Manabu Tanaka7, Yoshiko Nomura8, Yasuo Terao9, Ken Inoue10, Naomichi Matsumoto3, A James Barkovich11. 1. Department of Pediatrics, Kameda Medical Center, Kamogawa, Japan; Department of Radiology, Toho University Sakura Medical Center, Sakura, Japan. Electronic address: jtaka44@hotmail.co.jp. 2. Division of Neurology, Clinical Research Institute, Kanagawa Children's Medical Center, Yokohama, Japan. 3. Department of Human Genetics, Yokohama City University, Graduate School of Medicine, Yokohama, Japan. 4. Department of Child Neurology, National Center of Neurology and Psychiatry, Kodaira, Japan. 5. Department of Radiology, The University of Tokyo, Tokyo, Japan. 6. Department of Neurology, Kameda Medical Center, Kamogawa, Japan. 7. Division of Neurology, Saitama Children's Medical Center, Saitama, Japan. 8. Segawa Neurological Clinic for Children, Tokyo, Japan. 9. Department of Neurology, The University of Tokyo, Tokyo, Japan. 10. Department of Mental Retardation and Birth Defect Research, National Center of Neurology and Psychiatry, Kodaira, Japan. 11. Department of Radiology and Biomedical Imaging, University of California San Francisco, CA, USA.
Abstract
BACKGROUND: Mutations of POLR3A and POLR3B have been reported to cause several allelic hypomyelinating disorders, including hypomyelination with hypogonadotropic hypogonadism and hypodontia (4H syndrome). PATIENTS AND METHODS: To clarify the difference in MRI between the two genotypes, we reviewed MRI in three patients with POLR3B mutations, and three with POLR3A mutations. RESULTS: Though small cerebellar hemispheres and vermis are common MRI findings with both types of mutations, MRI in patients with POLR3B mutations revealed smaller cerebellar structures, especially vermis, than those in POLR3A mutations. MRI also showed milder hypomyelination in patients with POLR3B mutations than those with POLR3A mutations, which might explain milder clinical manifestations. CONCLUSIONS: MRI findings are distinct between patients with POLR3A and 3B mutations, and can provide important clues for the diagnosis, as these patients sometimes have no clinical symptoms suggesting 4H syndrome.
BACKGROUND: Mutations of POLR3A and POLR3B have been reported to cause several allelic hypomyelinating disorders, including hypomyelination with hypogonadotropic hypogonadism and hypodontia (4H syndrome). PATIENTS AND METHODS: To clarify the difference in MRI between the two genotypes, we reviewed MRI in three patients with POLR3B mutations, and three with POLR3A mutations. RESULTS: Though small cerebellar hemispheres and vermis are common MRI findings with both types of mutations, MRI in patients with POLR3B mutations revealed smaller cerebellar structures, especially vermis, than those in POLR3A mutations. MRI also showed milder hypomyelination in patients with POLR3B mutations than those with POLR3A mutations, which might explain milder clinical manifestations. CONCLUSIONS: MRI findings are distinct between patients with POLR3A and 3B mutations, and can provide important clues for the diagnosis, as these patients sometimes have no clinical symptoms suggesting 4H syndrome.
Keywords:
Cerebellum; Diffuse cerebral hypomyelination with cerebellar atrophy and hypoplasia of the corpus callosum (HCAHC); Hypomyelination; Hypomyelination with hypogonadotropic hypogonadism and hypodontia (4H syndrome); MRI; POLR3A; POLR3B; RNA polymerase III (Pol III)
Authors: Nicole I Wolf; Adeline Vanderver; Rosalina M L van Spaendonk; Raphael Schiffmann; Bernard Brais; Marianna Bugiani; Erik Sistermans; Coriene Catsman-Berrevoets; Johan M Kros; Pedro Soares Pinto; Daniela Pohl; Sandya Tirupathi; Petter Strømme; Ton de Grauw; Sébastien Fribourg; Michelle Demos; Amy Pizzino; Sakkubai Naidu; Kether Guerrero; Marjo S van der Knaap; Geneviève Bernard Journal: Neurology Date: 2014-10-22 Impact factor: 9.910
Authors: Martina Minnerop; Delia Kurzwelly; Holger Wagner; Anne S Soehn; Jennifer Reichbauer; Feifei Tao; Tim W Rattay; Michael Peitz; Kristina Rehbach; Alejandro Giorgetti; Angela Pyle; Holger Thiele; Janine Altmüller; Dagmar Timmann; Ilker Karaca; Martina Lennarz; Jonathan Baets; Holger Hengel; Matthis Synofzik; Burcu Atasu; Shawna Feely; Marina Kennerson; Claudia Stendel; Tobias Lindig; Michael A Gonzalez; Rüdiger Stirnberg; Marc Sturm; Sandra Roeske; Johanna Jung; Peter Bauer; Ebba Lohmann; Stefan Herms; Stefanie Heilmann-Heimbach; Garth Nicholson; Muhammad Mahanjah; Rajech Sharkia; Paolo Carloni; Oliver Brüstle; Thomas Klopstock; Katherine D Mathews; Michael E Shy; Peter de Jonghe; Patrick F Chinnery; Rita Horvath; Jürgen Kohlhase; Ina Schmitt; Michael Wolf; Susanne Greschus; Katrin Amunts; Wolfgang Maier; Ludger Schöls; Peter Nürnberg; Stephan Zuchner; Thomas Klockgether; Alfredo Ramirez; Rebecca Schüle Journal: Brain Date: 2017-06-01 Impact factor: 13.501
Authors: A K Singh; R C Upadhyay; Gulab Chandra; Sudarshan Kumar; D Malakar; S V Singh; M K Singh Journal: Cell Stress Chaperones Date: 2020-02-15 Impact factor: 3.667
Authors: Roberta La Piana; Ferdy K Cayami; Luan T Tran; Kether Guerrero; Rosalina van Spaendonk; Katrin Õunap; Sander Pajusalu; Tobias Haack; Evangeline Wassmer; Dagmar Timmann; Hanna Mierzewska; Bwee T Poll-Thé; Chirag Patel; Helen Cox; Tahir Atik; Huseyin Onay; Ferda Ozkınay; Adeline Vanderver; Marjo S van der Knaap; Nicole I Wolf; Geneviève Bernard Journal: Neurology Date: 2016-03-30 Impact factor: 9.910
Authors: E Jurkiewicz; D Dunin-Wąsowicz; D Gieruszczak-Białek; K Malczyk; K Guerrero; M Gutierrez; L Tran; G Bernard Journal: Clin Neuroradiol Date: 2015-10-19 Impact factor: 3.649
Authors: Marie Beaudin; Antoni Matilla-Dueñas; Bing-Weng Soong; Jose Luiz Pedroso; Orlando G Barsottini; Hiroshi Mitoma; Shoji Tsuji; Jeremy D Schmahmann; Mario Manto; Guy A Rouleau; Christopher Klein; Nicolas Dupre Journal: Cerebellum Date: 2019-12 Impact factor: 3.847